Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 314

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 314
---
 is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

(d) The undersigned registrant
hereby undertakes that:

| (1) | That for purposes of determining                                                                                                       
 any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration 
 statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1)          
 or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared    
 effective.                                                                                                                             |

| (2) | That for the purpose of                                                                                                              
 determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall   
 be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that 
 time shall be deemed to be the initial bona fide offering thereof.                                                                   |

<div align='center'>II-6

EXHIBIT INDEX</div>

| EXHIBIT 
 NUMBER  |     | EXHIBIT DESCRIPTION                                                                                                                                                                                                                             |
| 1.1*    |     | Form of Underwriting Agreement                                                                                                                                                                                                                  |
| 3.1*    |     | Amended and Restated Articles of Association of the Registrant, as currently in effect                                                                                                                                                          |
| 3.2*    |     | Form of Amended and Restated Articles of Association of the Registrant to be in effect upon the consummation of this offering                                                                                                                   |
| 4.1*    |     | Form of Representative’s Warrant                                                                                                                                                                                                                |
| 4.2*    |     | Amended and Restated Investors’ Rights Agreement, by and among Regentis Biomaterials Ltd., HaisThera Scientific Fund L.P. and the Owners and Holders of Series D-1 Preferred Shares and Series D-2 Preferred Shares, dated February 4, 2016     |
| 5.1*    |     | Opinion of Doron Tikotzky Kantor Gutman & Amit Gross, Israeli counsel to the Registrant, as to the validity of the Ordinary Shares                                                                                                              |
| 5.2*    |     | Opinion of Greenberg Traurig, LLP                                                                                                                                                                                                               |
| 10.1*+  |     |